Arinilda Campos Bragagnoli

Years Active: 2021-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kohei Shitara, Jaffer A Ajani, Markus Moehler, Marcelo Garrido, Carlos Gallardo, Lin Shen, Kensei Yamaguchi, Lucjan Wyrwicz, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshu Liu, Mustapha Tehfe, Elena Elimova, Ricardo Bruges, Thomas Zander, Sergio de Azevedo, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, James M Cleary, Patricio Yanez, Kynan Feeney, Michalis V Karamouzis, Valerie Poulart, Ming Lei, Hong Xiao, Kaoru Kondo, Mingshun Li, Yelena Y Janjigian
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer. Nature 603 (7903) (2022)
Arinilda Campos Bragagnoli, Raphael L C Araujo, Mauricio Wagner Ferraz, Lucas Vieira Dos Santos, Kathia Cristina Abdalla, Fabiana Comar, Florinda Almeida Santos, Marco Antonio Oliveira, José Barreto Campello Carvalheira, Flávio Mavigner Cárcano, João Paulo da Silveira Nogueira Lima
Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial. British journal of cancer 124 (6) (2021)
Carolina Fumico Massuda Araujo, Lélia Cápua Nunes, Cristiane Murta-Nascimento, Cristiano de Pádua Souza, Arinilda Campos Bragagnoli, Fernanda Bono Fukushima, Edison Iglesias de Oliveira Vidal
Metformin for the treatment of breast cancer: protocol for a scoping review of randomised clinical trials. BMJ open 11 (8) (2021)

Arinilda Campos Bragagnoli.css-eqlu8i{font-size:small;padding-left:4px;}